Research News and Research

RSS

Roche announces results of phase III taspoglutide study in diabetes patients

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen’s research and developed by Roche.

2 Dec 2009

Bioactive sponge to eliminate normally fatal tumors

InCytu Incorporated, a therapeutic device engineering company, announced the details of its Cellarium™ Cancer Vaccine program. Cellarium™ is a small bioactive sponge which regulates dendritic cells and T-cells to eliminate normally fatal tumors in a preclinical model of late stage melanoma. The details of such a promising new vaccine were published for the first time in Science’s Translational Medicine Journal.

2 Dec 2009

Infections remain a common problem in ICU patients

An international study that examined the extent of infections in nearly 1,300 intensive care units (ICUs) in 75 countries found that about 50 percent of the patients were considered infected, with infection associated with an increased risk of death in the hospital, according to a study in the December 2 issue of JAMA.

2 Dec 2009

Harvest Technologies' BMAC System exhibits potential as an effective treatment for CLI

Harvest Technologies Corp. announced today results from the company sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical Center in Chennai, India using the company's BMAC System to treat patients with non-reconstructable Critical Limb Ischemia (CLI). Sri Ramachandra Medical Center is a Harvard Medical international-associated institution based in Chennai, India and one of the largest private healthcare facilities in South Asia.

2 Dec 2009

Guardian Technologies International introduces Signature Mapping TBDx to diagnose TB

Guardian Technologies International is bringing the diagnosis of tuberculosis (TB) into the 21st century with Signature Mapping TBDx™ (SM TBDx), an automated diagnostic solution using sophisticated detection algorithms to identify TB under microscopy in sputum samples, at the laboratory level.

2 Dec 2009

Controlling NTDs can improve reproductive health and rights of women in poor countries

Controlling neglected tropical diseases (NTDs) in developing countries would help improve the reproductive health and rights of girls and women in the poorest countries of Africa, Asia, Latin America, and the Caribbean, according to a new editorial published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

2 Dec 2009

Cancer Prevention Research Conference highlights new research on cancer

The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.

2 Dec 2009

Affordable Health Care Act to increase number of insured Americans by 36 million

According to Fitch Ratings' Fall U.S. Healthcare Sector Legislative and Regulatory Register, the Affordable Health Care for America Act of 2009 (H.R. 3962) passed by the House of Representatives on Nov. 7, 2009 will generally increase the number of insured Americans by 36 million through individual and employer mandates, coupled with a number of subsidies offered to lower-income individuals and smaller employers.

2 Dec 2009

ASH Annual Meeting to showcase latest research and treatments for blood disorders

The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. The meeting will showcase the latest research and treatments for blood disorders.

2 Dec 2009

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

The Georgia Institute of Technology has been awarded a U.S. Air Force Center of Excellence to design nanostructures for energy harvesting and adaptive materials, and to develop tools to optimize critical cognitive processes of the modern warfighter.

2 Dec 2009

Baker College Online's new BSN degree program for registered nurses

Baker College Online officials today announced its new Baccalaureate of Science in Nursing (BSN) degree program. The BSN is based on accreditation standards established by the Commission on Collegiate Nursing Education (CCNE). Registration for the new program is now underway for winter 2010 quarter.

2 Dec 2009

New approach to identify molecules that prevent immune cells from attacking body

A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host. The findings add a powerful new tool to the ongoing search for potential treatments for autoimmune diseases, such as multiple sclerosis (MS), as well as blood cancers, such as myeloid leukemia.

2 Dec 2009

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.’s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.

2 Dec 2009

Researchers develop new application for improved detection of breast cancer cells

Single-walled nanotubes—cylinders of carbon about a nanometer in diameter—have been highly touted for potential applications such as ultrastrong fibers, electrical wires in molecular devices, or hydrogen storage components for fuel cells. Thanks to a new development by researchers at the National Institute of Standards and Technology (NIST) and five partners, you can add one more application to the list: detection and destruction of an aggressive form of breast cancer.

2 Dec 2009

J&JPRD submits an NDA for tapentadol ER tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.

2 Dec 2009

Despite price transparency legislation in California, uninsured patients do not receive price estimates

Uninsured patients in California are unable to successfully obtain information about the cost of medical care at hospitals despite recent state legislation intended to improve price transparency, according to a new study.

2 Dec 2009

DiaMedica to acquire all issued and outstanding shares of Sanomune

DiaMedica Inc. (TSX VENTURE:DMA)("Diamedica"), a biopharmaceutical company that has discovered and is developing a novel approach to treating diabetes, announces it has entered into a non-binding letter of intent to acquire all of the issued and outstanding shares of Sanomune Inc.

2 Dec 2009

MUHC researchers identify first genetic resistance factor against TB infection

Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with Dr. Alexandre Alcais, from the Institut national de la sant- et de la recherche m-dicale (INSERM) in Paris, has shed light on this question for the first time. Their

2 Dec 2009

CT imaging combined with Avastin may predict overall survival in metastatic colorectal cancer

Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University of Texas M. D. Anderson Cancer Center.

2 Dec 2009

CRi announces study results of imaging and analysis platform for drug and molecular diagnostic development

Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, today announced the results of a study demonstrating for the first time the capability to detect and automatically measure key activity indicators of cancer cell signal transduction pathways in intact tissue.

2 Dec 2009

Research News and Research

Roche announces results of phase III taspoglutide study in diabetes patients

Bioactive sponge to eliminate normally fatal tumors

Infections remain a common problem in ICU patients

Harvest Technologies' BMAC System exhibits potential as an effective treatment for CLI

Guardian Technologies International introduces Signature Mapping TBDx to diagnose TB

Controlling NTDs can improve reproductive health and rights of women in poor countries

Cancer Prevention Research Conference highlights new research on cancer

Affordable Health Care Act to increase number of insured Americans by 36 million

ASH Annual Meeting to showcase latest research and treatments for blood disorders

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

Baker College Online's new BSN degree program for registered nurses

New approach to identify molecules that prevent immune cells from attacking body

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Researchers develop new application for improved detection of breast cancer cells

J&JPRD submits an NDA for tapentadol ER tablets

Despite price transparency legislation in California, uninsured patients do not receive price estimates

DiaMedica to acquire all issued and outstanding shares of Sanomune

MUHC researchers identify first genetic resistance factor against TB infection

CT imaging combined with Avastin may predict overall survival in metastatic colorectal cancer

CRi announces study results of imaging and analysis platform for drug and molecular diagnostic development

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring